6,869 Shares in Danaher Co. (NYSE:DHR) Acquired by Tema Etfs LLC

Tema Etfs LLC acquired a new stake in shares of Danaher Co. (NYSE:DHR - Free Report) during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm acquired 6,869 shares of the conglomerate's stock, valued at approximately $1,577,000.

Several other institutional investors and hedge funds have also recently modified their holdings of DHR. Heck Capital Advisors LLC bought a new stake in shares of Danaher during the fourth quarter valued at approximately $27,000. Decker Retirement Planning Inc. purchased a new position in shares of Danaher in the fourth quarter valued at $31,000. Golden State Wealth Management LLC purchased a new position in shares of Danaher in the fourth quarter valued at $31,000. Strategic Financial Concepts LLC purchased a new position in shares of Danaher in the fourth quarter valued at $31,000. Finally, Pineridge Advisors LLC grew its holdings in shares of Danaher by 63.3% in the fourth quarter. Pineridge Advisors LLC now owns 147 shares of the conglomerate's stock valued at $34,000 after purchasing an additional 57 shares in the last quarter. Institutional investors own 79.05% of the company's stock.

Analysts Set New Price Targets

DHR has been the subject of a number of recent research reports. Stifel Nicolaus raised shares of Danaher from a "hold" rating to a "buy" rating and set a $260.00 target price for the company in a report on Friday, March 14th. JPMorgan Chase & Co. dropped their price objective on shares of Danaher from $280.00 to $260.00 and set an "overweight" rating for the company in a research note on Tuesday, April 22nd. Citigroup reaffirmed a "buy" rating on shares of Danaher in a research note on Monday, April 7th. Raymond James reaffirmed a "market perform" rating on shares of Danaher in a research note on Monday, February 3rd. Finally, The Goldman Sachs Group dropped their price objective on shares of Danaher from $260.00 to $240.00 and set a "neutral" rating for the company in a research note on Wednesday, April 23rd. Four equities research analysts have rated the stock with a hold rating and seventeen have assigned a buy rating to the company's stock. According to MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and a consensus target price of $263.24.

Danaher Stock Performance

Shares of NYSE DHR traded up $1.27 during mid-day trading on Tuesday, hitting $197.68. 2,872,647 shares of the company were exchanged, compared to its average volume of 3,455,650. Danaher Co. has a 1-year low of $171.00 and a 1-year high of $281.70. The company has a quick ratio of 1.05, a current ratio of 1.40 and a debt-to-equity ratio of 0.31. The stock has a 50 day simple moving average of $196.56 and a 200-day simple moving average of $216.78. The firm has a market cap of $141.47 billion, a price-to-earnings ratio of 37.44, a price-to-earnings-growth ratio of 2.66 and a beta of 0.80.

Danaher (NYSE:DHR - Get Free Report) last announced its earnings results on Tuesday, April 22nd. The conglomerate reported $1.88 earnings per share for the quarter, beating the consensus estimate of $1.62 by $0.26. The firm had revenue of $5.74 billion during the quarter, compared to the consensus estimate of $5.58 billion. Danaher had a net margin of 16.33% and a return on equity of 10.82%. On average, sell-side analysts forecast that Danaher Co. will post 7.63 EPS for the current fiscal year.

Danaher Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, July 25th. Stockholders of record on Friday, June 27th will be issued a $0.32 dividend. This represents a $1.28 dividend on an annualized basis and a dividend yield of 0.65%. Danaher's dividend payout ratio (DPR) is 24.85%.

Insider Buying and Selling

In other news, EVP Christopher Paul Riley sold 15,805 shares of the firm's stock in a transaction dated Wednesday, April 30th. The stock was sold at an average price of $198.00, for a total transaction of $3,129,390.00. Following the completion of the sale, the executive vice president now directly owns 15,179 shares of the company's stock, valued at $3,005,442. This trade represents a 51.01% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, Chairman Steven M. Rales sold 1,250,000 shares of the stock in a transaction dated Monday, May 12th. The shares were sold at an average price of $196.74, for a total value of $245,925,000.00. Following the transaction, the chairman now directly owns 3,105,808 shares in the company, valued at approximately $611,036,665.92. This represents a 28.70% decrease in their position. The disclosure for this sale can be found here. 11.10% of the stock is owned by company insiders.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.